Related Experiment Video
Updated: Sep 12, 2025
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.7K
Increasing statin prescribing through a pharmacogenomics-guided initiative
Journal of the American Pharmacists Association : Japha
|August 10, 2025
Summary
Pharmacogenomics testing helps Veterans start statin therapy, improving adherence and tolerance. This genetic approach guides personalized statin prescriptions, overcoming intolerance concerns.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacy
- Quality Improvement
Background:
- Suboptimal statin therapy utilization is linked to adverse effect concerns and genetic predispositions to statin intolerance.
- Personalized medicine approaches are needed to optimize cardiovascular disease prevention strategies.
Purpose of the Study:
- To implement pharmacogenomics testing for Veterans to guide statin therapy decisions.
- To increase appropriate statin prescribing within a Veterans Affairs Health Care System (VAHCS).
Main Methods:
- A quality improvement initiative involved pharmacists offering pharmacogenomics testing and statin initiation via personalized phone calls.
- Patient adherence and tolerability were assessed at least four weeks post-statin initiation.
Main Results:
- Out of 107 patients contacted, 50 initiated statin therapy, with 45 (90%) completing pharmacogenomics testing for guided prescriptions.
- A majority of patients (72%) reported good adherence and tolerance to statin therapy after four weeks.
Conclusions:
- Pharmacogenomics testing can enhance patient-centered discussions and shared decision-making in statin therapy initiation.
- Genomic guidance may improve the successful implementation of statin therapy in clinical practice.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
871
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
871
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:11Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
01:21Pharmacodynamics: Overview and Principles
2.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.1K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114